Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Controlled Trial to Evaluate the Efficacy of Intra-pericardial Instillation of a Sclerosing Agent After Pericardial Drainage in Patients With Malignant Pericardial Effusion Associated With Lung Cancer (JCOG9811)

NCT00132613 is registered in ClinicalTrials.gov with Japan Clinical Oncology Group as lead sponsor.

NCT NCT00132613
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00132613 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Controlled Trial to Evaluate the Efficacy of Intra-pericardial Instillation of a Sclerosing Agent After Pericardial Drainage in Patients With Malignant Pericardial Effusion Associated With Lung Cancer (JCOG9811)
Lead sponsor
Japan Clinical Oncology Group
Phase
Phase 3
Overall status
Completed
Start date
August 31, 1999
Completion date
November 30, 2006
Enrollment
80 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

malignant pericardial effusion